Frequency of Coexisting Adenomyosis in Women with Uterine Leiomyomas: MRI Findings and Detection by Transabdominal Ultrasound
Background: Adenomyosis often coexists with uterine leiomyomas and affects uterus-sparing treatment, but it is difficult to see on transabdominal ultrasound (US). We assessed how often MRI showed adenomyosis in women with a leiomyoma as the main lesion, and whether the preceding US reported it.
Methods: We reviewed the reports of 91 consecutive women who underwent transabdominal US followed by 1.5-T pelvic MRI for a gynaecological indication in Jazan, Saudi Arabia (May 2022–July 2025). Women whose main MRI lesion was a leiomyoma formed the study group. We assessed agreement between US and MRI using Cohen’s kappa, PABAK, and the exact McNemar test, and compared groups using Fisher’s exact and Mann–Whitney U tests.
Results: Fifty-one women (mean age 44.1 ± 9.5 years) had a leiomyoma as the main lesion, and 13 of them (25.5%; 95% CI 14.3–39.6) also had adenomyosis on MRI. Age was similar (43.2 vs 44.4 years; p = 0.72), but women with coexisting adenomyosis were more often referred for menstrual symptoms (38.5% vs 10.5%; p = 0.036). In these 13 women, transabdominal US reported a leiomyoma in 11 and an ovarian or adnexal cyst in 2, and it reported adenomyosis in none (0/13; 95% CI 0–24.7; κ = 0.00; PABAK = 0.49; McNemar p < 0.001).
Conclusion: About one in four women with a leiomyoma on MRI also had adenomyosis, which the preceding transabdominal US did not report. MRI should be considered before uterus-sparing treatment of presumed leiomyomas, particularly in women with heavy bleeding or dysmenorrhoea.
